Trial · NCT03070730
Outcomes42
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 42
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Maximal Postural Tachycardia During Tilt | Up to 3 days after randomization | |||
| PRIMARY | Change Maximal Postural Tachycardia During Tilt | 2 weeks after first intervention | |||
| PRIMARY | Change Maximal Postural Tachycardia During Tilt | 2 weeks after second intervention | |||
| PRIMARY | Change in Fatigue Score on the Chalder Fatigue Questionnaire From Baseline | up to 3 days after randomization | |||
| PRIMARY | Change in Fatigue Score on the Chalder Fatigue Questionnaire From Baseline | 2 weeks after first intervention | |||
| PRIMARY | Change in Fatigue Score on the Chalder Fatigue Questionnaire From Baseline | 2 weeks after second intervention | |||
| SECONDARY | Change in Blood Pressure From Baseline | 1 week after first intervention | |||
| SECONDARY | Change in Blood Pressure From Baseline | 1 week after second intervention | |||
| SECONDARY | Change in Blood Pressure From Baseline | 1 week after third intervention | |||
| SECONDARY | Change in Heart Rate From Baseline | 1 week after first intervention | |||
| SECONDARY | Change in Heart Rate From Baseline | 1 week after second intervention | |||
| SECONDARY | Change in Heart Rate From Baseline | 1 week after third intervention | |||
| SECONDARY | Change in Vascular Resistance From Baseline | 1 week after first intervention | |||
| SECONDARY | Change in Vascular Resistance From Baseline | 1 week after second intervention | |||
| SECONDARY | Change in Vascular Resistance From Baseline | 1 week after third intervention | |||
| SECONDARY | Change in Muscle Sympathetic Nerve Activity From Baseline | 1 week after first intervention | |||
| SECONDARY | Change in Muscle Sympathetic Nerve Activity From Baseline | 1 week after second intervention | |||
| SECONDARY | Change in Muscle Sympathetic Nerve Activity From Baseline | 1 week after third intervention | |||
| SECONDARY | Change in Physical Functioning-SF-36 Q From Baseline | 1 week after first intervention | |||
| SECONDARY | Change in Physical Functioning-SF-36 Q From Baseline | 1 week after second intervention |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03070730/outcomes